• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by Lumexa Imaging Holdings Inc.

    2/13/26 2:36:25 PM ET
    $LMRI
    Medical Specialities
    Health Care
    Get the next $LMRI alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    Lumexa Imaging Holdings, Inc.

    (Name of Issuer)


    Common Stock, $0.001 par value

    (Title of Class of Securities)


    550249106

    (CUSIP Number)


    12/31/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox not checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    550249106


    1Names of Reporting Persons

    Welsh, Carson, Anderson & Stowe XII, L.P.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    70,217,616.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    70,217,616.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    70,217,616.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    74.3 %
    12Type of Reporting Person (See Instructions)

    PN


    SCHEDULE 13G

    CUSIP No.
    550249106


    1Names of Reporting Persons

    WCAS XII Associates LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    70,217,616.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    70,217,616.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    70,217,616.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    74.3 %
    12Type of Reporting Person (See Instructions)

    OO


    SCHEDULE 13G

    CUSIP No.
    550249106


    1Names of Reporting Persons

    WCAS Management Corporation
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    70,217,616.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    70,217,616.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    70,217,616.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    74.3 %
    12Type of Reporting Person (See Instructions)

    CO


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Lumexa Imaging Holdings, Inc.
    (b)Address of issuer's principal executive offices:

    4200 Six Forks Road, Suite 1000, Raleigh, NC 27609
    Item 2. 
    (a)Name of person filing:

    This Schedule 13G is filed by (i) Welsh, Carson, Anderson & Stowe XII, L.P. ("WCAS XII"); (ii) WCAS XII Associates LLC ("XII Associates"), as the general partner of WCAS XII; and (iii) WCAS Management Corporation ("WCAS Management"), as the investment adviser to WCAS XII (each, a "Reporting Person" and collectively, the "Reporting Persons"). The agreement among the Reporting Persons to file the Schedule 13G jointly (the "Joint Filing Agreement") is filed herewith as Exhibit A.
    (b)Address or principal business office or, if none, residence:

    599 Lexington Avenue, Suite 1800, New York, NY 10022
    (c)Citizenship:

    WCAS XII is a Delaware limited partnership. XII Associates is a Delaware limited liability company. WCAS Management is a Delaware corporation.
    (d)Title of class of securities:

    Common Stock, $0.001 par value
    (e)CUSIP No.:

    550249106
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    The information required by this paragraph is set forth in the cover pages to this Schedule 13G and is incorporated herein by reference. The shares reported herein as beneficially owned by the Reporting Persons are held by Lumexa Imaging Holdings, LLC ("Holdings LLC"). WCAS XII has the right under the LLC Agreement of Holdings LLC to designate a majority of the members of the Board of Managers of Holdings LLC and, as a result, shares beneficial ownership over the shares held by Holdings LLC. After the expiration of a 180-day lock-up period following the closing of the Issuer's initial public offering on December 12, 2025, Holdings LLC may distribute all or a portion of the shares of Common Stock it holds to its equity holders on a pro rata basis (a "Distribution"). The shares reported herein include up to 28,595,386 shares that could be received by affiliates of Welsh, Carson, Anderson & Stowe in connection with a full Distribution, as follows: (i) 17,995,515 shares that represent WCAS XII's maximum pro-rata interest in Holdings LLC; (ii) 49,981 shares that represent WCAS Management's maximum pro-rata interest in Holdings LLC; (iii) 3,282,597 shares that represent Welsh, Carson, Anderson & Stowe XII Cayman, L.P.'s maximum pro-rata interest in Holdings LLC; (iv) 526,810 shares that represent Welsh, Carson, Anderson & Stowe XII Delaware II, L.P.'s maximum pro-rata interest in Holdings LLC; (v) 3,171,591 shares that represent Welsh, Carson, Anderson & Stowe XII Delaware, L.P.'s maximum pro-rata interest in Holdings LLC; (vi) 236,854 shares that represent WCAS XII Co-Investors LLC's maximum pro-rata interest in Holdings LLC; and (vii) 3,332,038 shares that represent WCAS-Co-Invest Holdco, L.P.'s maximum pro-rata interest in Holdings LLC. Upon a full Distribution, the remaining shares set forth in the cover pages to this Schedule 13G would be distributed to persons unaffiliated with the Reporting Persons and the Reporting Persons will cease to share beneficial ownership over such shares.
    (b)Percent of class:

    The information required by this paragraph is set forth in the cover pages to this Schedule 13G and is incorporated herein by reference. Percentage ownership is based on 94,565,652 shares of Common Stock outstanding after the completion of the Issuer's initial public offering, as reported in the Issuer's final prospectus on Form 424B4 dated December 10, 2025 and filed with the Securities and Exchange Commission on December 12, 2025.
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    The information required by this paragraph is set forth in the cover pages to this Schedule 13G and is incorporated herein by reference.

     (ii) Shared power to vote or to direct the vote:

    The information required by this paragraph is set forth in the cover pages to this Schedule 13G and is incorporated herein by reference.

     (iii) Sole power to dispose or to direct the disposition of:

    The information required by this paragraph is set forth in the cover pages to this Schedule 13G and is incorporated herein by reference.

     (iv) Shared power to dispose or to direct the disposition of:

    The information required by this paragraph is set forth in the cover pages to this Schedule 13G and is incorporated herein by reference.

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Not Applicable
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    Not Applicable

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Welsh, Carson, Anderson & Stowe XII, L.P.
     
    Signature:/s/ Jennifer Martin
    Name/Title:Jennifer Martin/Authorized Signatory
    Date:02/13/2026
     
    WCAS XII Associates LLC
     
    Signature:/s/ Jennifer Martin
    Name/Title:Jennifer Martin/Authorized Signatory
    Date:02/13/2026
     
    WCAS Management Corporation
     
    Signature:/s/ Jennifer Martin
    Name/Title:Jennifer Martin/Authorized Signatory
    Date:02/13/2026
    Exhibit Information

    Exhibit A - Joint Filing Agreement

    Get the next $LMRI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LMRI

    DatePrice TargetRatingAnalyst
    2/9/2026$23.00Outperform → Strong Buy
    Raymond James
    1/5/2026$23.00Overweight
    Analyst
    1/5/2026$23.00Buy
    Jefferies
    1/5/2026$22.00Overweight
    Wells Fargo
    1/5/2026Outperform
    William Blair
    1/5/2026$23.00Outperform
    Raymond James
    1/5/2026$23.00Outperform
    Leerink Partners
    1/5/2026$22.00Buy
    Deutsche Bank
    More analyst ratings

    $LMRI
    SEC Filings

    View All

    Lumexa Imaging Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure

    8-K - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)

    3/2/26 6:14:27 AM ET
    $LMRI
    Medical Specialities
    Health Care

    SEC Form SCHEDULE 13G filed by Lumexa Imaging Holdings Inc.

    SCHEDULE 13G - Lumexa Imaging Holdings, Inc. (0002071288) (Subject)

    2/13/26 2:36:25 PM ET
    $LMRI
    Medical Specialities
    Health Care

    SEC Form 8-K filed by Lumexa Imaging Holdings Inc.

    8-K - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)

    1/15/26 6:48:58 AM ET
    $LMRI
    Medical Specialities
    Health Care

    $LMRI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Principal Accounting Officer Walker James Edward Jr. was granted 12,414 shares, increasing direct ownership by 252% to 17,346 units (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    2/27/26 5:40:01 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Chief Financial Officer Martin James Anthony was granted 54,054 shares (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    1/15/26 12:51:17 PM ET
    $LMRI
    Medical Specialities
    Health Care

    SEC Form 3 filed by new insider Martin James Anthony

    3 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    1/15/26 12:49:28 PM ET
    $LMRI
    Medical Specialities
    Health Care

    $LMRI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Middleby Appoints Glenn Eisenberg To Board of Directors

    The Middleby Corporation (NASDAQ:MIDD), a global leader in the foodservice industry, today announced the appointment of Glenn Eisenberg to its Board of Directors, effective March 1. With the addition of Mr. Eisenberg, the Middleby Board expands to twelve members. "We are pleased to welcome Glenn Eisenberg to the Middleby Board. His deep experience will be an immediate asset as we execute our strategic transformation," said Tim FitzGerald, Middleby CEO. "Glenn has a proven 20-year track record of success as a public company CFO and senior operating executive across complex global manufacturing businesses. His expertise in financial discipline, industrial manufacturing, capital allocation,

    3/6/26 7:00:00 AM ET
    $LH
    $LMRI
    $MIDD
    Medical Specialities
    Health Care
    Industrial Machinery/Components
    Industrials

    Lumexa Imaging Announces Participation in Upcoming Investor Conferences

    RALEIGH, N.C., Feb. 17, 2026 /PRNewswire/ -- Lumexa Imaging Holdings, Inc. ("Lumexa Imaging") (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, announced today that Caitlin Zulla, CEO, and Tony Martin, CFO, will participate in the following upcoming investor conferences: Raymond James Institutional Investors Conference, being held in Orlando, Florida, including a presentation at 3:25pm EST on Monday, March 2, 2026.Leerink Partners Global Healthcare Conference, being held in Miami, Florida, including a fireside chat at 8:40am EST on Monday, Marc

    2/17/26 7:30:00 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging's Dr. Jennifer L. Kemp Elected to RSNA Board, Advancing National Leadership in Quality and Patient-Centered Care

    Chair of Lumexa Imaging's Center for Quality will serve as the Radiological Society of North America's board liaison for government relations RALEIGH, N.C., Jan. 28, 2026 /PRNewswire/ -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, is proud to recognize Jennifer L. Kemp, MD, Chair of Lumexa Imaging's Center for Quality, has been elected to the Board of Directors of the Radiological Society of North America (RSNA). "Dr. Kemp's election to the RSNA Board reflects the depth of clinical leadership within our organization and t

    1/28/26 7:00:00 AM ET
    $LMRI
    Medical Specialities
    Health Care

    $LMRI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lumexa Imaging Holdings upgraded by Raymond James with a new price target

    Raymond James upgraded Lumexa Imaging Holdings from Outperform to Strong Buy and set a new price target of $23.00

    2/9/26 8:16:45 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Analyst initiated coverage on Lumexa Imaging Holdings with a new price target

    Analyst initiated coverage of Lumexa Imaging Holdings with a rating of Overweight and set a new price target of $23.00

    1/5/26 9:16:52 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Jefferies initiated coverage on Lumexa Imaging Holdings with a new price target

    Jefferies initiated coverage of Lumexa Imaging Holdings with a rating of Buy and set a new price target of $23.00

    1/5/26 8:58:21 AM ET
    $LMRI
    Medical Specialities
    Health Care

    $LMRI
    Leadership Updates

    Live Leadership Updates

    View All

    Middleby Appoints Glenn Eisenberg To Board of Directors

    The Middleby Corporation (NASDAQ:MIDD), a global leader in the foodservice industry, today announced the appointment of Glenn Eisenberg to its Board of Directors, effective March 1. With the addition of Mr. Eisenberg, the Middleby Board expands to twelve members. "We are pleased to welcome Glenn Eisenberg to the Middleby Board. His deep experience will be an immediate asset as we execute our strategic transformation," said Tim FitzGerald, Middleby CEO. "Glenn has a proven 20-year track record of success as a public company CFO and senior operating executive across complex global manufacturing businesses. His expertise in financial discipline, industrial manufacturing, capital allocation,

    3/6/26 7:00:00 AM ET
    $LH
    $LMRI
    $MIDD
    Medical Specialities
    Health Care
    Industrial Machinery/Components
    Industrials